Your browser doesn't support javascript.
loading
Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases.
Bitoun, Samuel; Henry, Julien; Desjardins, Delphine; Vauloup-Fellous, Christelle; Dib, Nicolas; Belkhir, Rakiba; Mouna, Lina; Joly, Candie; Bitu, Marie; Ly, Bineta; Pascaud, Juliette; Seror, Raphaèle; Roque Afonso, Anne-Marie; Le Grand, Roger; Mariette, Xavier.
Afiliación
  • Bitoun S; Hôpital Bicêtre, AP-HP, FHU CARE, and Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Henry J; Hôpital Bicêtre, AP-HP, FHU CARE, Paris, France.
  • Desjardins D; Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Vauloup-Fellous C; Université Paris Saclay, INSERM U1193, AP-HP, Paris, France, and Hôpital Paul Brousse, Villejuif, France.
  • Dib N; Hôpital Bicêtre, AP-HP, FHU CARE, Paris, France.
  • Belkhir R; Hôpital Bicêtre, AP-HP, FHU CARE, Paris, France.
  • Mouna L; Université Paris Saclay, INSERM U1193, AP-HP, Paris, France, and Hôpital Paul Brousse, Villejuif, France.
  • Joly C; Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Bitu M; Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Ly B; Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Pascaud J; Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Seror R; Hôpital Bicêtre, AP-HP, FHU CARE, and Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Roque Afonso AM; Université Paris Saclay, INSERM U1193, AP-HP, Paris, France, and Hôpital Paul Brousse, Villejuif, France.
  • Le Grand R; Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
  • Mariette X; Hôpital Bicêtre, AP-HP, FHU CARE, and Université Paris-Saclay, INSERM UMR 1184, CEA, Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Paris, France.
Arthritis Rheumatol ; 74(6): 927-933, 2022 06.
Article en En | MEDLINE | ID: mdl-34962357
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Vacunas contra la COVID-19 / COVID-19 / Vacuna BNT162 / Anticuerpos Antivirales Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Vacunas contra la COVID-19 / COVID-19 / Vacuna BNT162 / Anticuerpos Antivirales Límite: Humans Idioma: En Revista: Arthritis Rheumatol Año: 2022 Tipo del documento: Article País de afiliación: Francia